AbbVie Inc. (ABBV) Free Cash Flow
AbbVie Inc. (ABBV) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $6.33B |
| 2017-12-31 | $8.80B |
| 2018-12-31 | $12.75B |
| 2019-12-31 | $9.73B |
| 2020-12-31 | $11.03B |
| 2021-12-31 | $21.99B |
| 2022-12-31 | $24.25B |
| 2023-12-31 | $22.06B |
| 2024-12-31 | $17.83B |
| 2025-12-31 | $17.82B |
How ABBV compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| JNJ | Johnson & Johnson | $19.70B |
| BMY | Bristol-Myers Squibb Company | $12.85B |
| MRK | Merck & Company Inc. | $12.36B |
| CI | The Cigna Group | $9.60B |
| GILD | Gilead Sciences Inc. | $9.46B |
These are five companies in the same sector as ABBV with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get AbbVie Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ABBV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ABBV | $264.52 | -0.17% | 3.88M |
| 3 | ||||
| 4 | ||||
| 5 |